List of Tables
    Table 1. Sickle Cell Disease Treatments Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Sickle Cell Disease Treatments Market Trends
    Table 3. Sickle Cell Disease Treatments Market Drivers
    Table 4. Sickle Cell Disease Treatments Market Challenges
    Table 5. Sickle Cell Disease Treatments Market Restraints
    Table 6. Global Sickle Cell Disease Treatments Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Sickle Cell Disease Treatments Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Sickle Cell Disease Treatments Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Sickle Cell Disease Treatments Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Sickle Cell Disease Treatments Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Sickle Cell Disease Treatments Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Sickle Cell Disease Treatments Revenue Share by Player, 2017-2022
    Table 13. Global Sickle Cell Disease Treatments Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Sickle Cell Disease Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatments as of 2021)
    Table 15. Top Players of Sickle Cell Disease Treatments in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Sickle Cell Disease Treatments Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Sickle Cell Disease Treatments Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Sickle Cell Disease Treatments Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Sickle Cell Disease Treatments Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Sickle Cell Disease Treatments Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Sickle Cell Disease Treatments Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Sickle Cell Disease Treatments Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Sickle Cell Disease Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Sickle Cell Disease Treatments Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Sickle Cell Disease Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Sickle Cell Disease Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Sickle Cell Disease Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. AstraZeneca Company Details
    Table 31. AstraZeneca Business Overview
    Table 32. AstraZeneca Sickle Cell Disease Treatments Product
    Table 33. AstraZeneca Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 34. AstraZeneca Recent Development
    Table 35. Eli Lilly Company Details
    Table 36. Eli Lilly Business Overview
    Table 37. Eli Lilly Sickle Cell Disease Treatments Product
    Table 38. Eli Lilly Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 39. Eli Lilly Recent Development
    Table 40. Bristol-Myers Squibb Company Details
    Table 41. Bristol-Myers Squibb Business Overview
    Table 42. Bristol-Myers Squibb Sickle Cell Disease Treatments Product
    Table 43. Bristol-Myers Squibb Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 44. Bristol-Myers Squibb Recent Development
    Table 45. Novartis Company Details
    Table 46. Novartis Business Overview
    Table 47. Novartis Sickle Cell Disease Treatments Product
    Table 48. Novartis Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 49. Novartis Recent Development
    Table 50. Pfizer Company Details
    Table 51. Pfizer Business Overview
    Table 52. Pfizer Sickle Cell Disease Treatments Product
    Table 53. Pfizer Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 54. Pfizer Recent Development
    Table 55. Baxter Company Details
    Table 56. Baxter Business Overview
    Table 57. Baxter Sickle Cell Disease Treatments Product
    Table 58. Baxter Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 59. Baxter Recent Development
    Table 60. Emmaus Life Sciences Company Details
    Table 61. Emmaus Life Sciences Business Overview
    Table 62. Emmaus Life Sciences Sickle Cell Disease Treatments Product
    Table 63. Emmaus Life Sciences Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 64. Emmaus Life Sciences Recent Development
    Table 65. Bluebird Bio Company Details
    Table 66. Bluebird Bio Business Overview
    Table 67. Bluebird Bio Sickle Cell Disease Treatments Product
    Table 68. Bluebird Bio Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 69. Bluebird Bio Recent Development
    Table 70. Global Blood Therapeutics Company Details
    Table 71. Global Blood Therapeutics Business Overview
    Table 72. Global Blood Therapeutics Sickle Cell Disease Treatments Product
    Table 73. Global Blood Therapeutics Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 74. Global Blood Therapeutics Recent Development
    Table 75. Sangamo Therapeutics Company Details
    Table 76. Sangamo Therapeutics Business Overview
    Table 77. Sangamo Therapeutics Sickle Cell Disease Treatments Product
    Table 78. Sangamo Therapeutics Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 79. Sangamo Therapeutics Recent Development
    Table 80. Acceleron Pharma Company Details
    Table 81. Acceleron Pharma Business Overview
    Table 82. Acceleron Pharma Sickle Cell Disease Treatments Product
    Table 83. Acceleron Pharma Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 84. Acceleron Pharma Recent Development
    Table 85. Arena Pharmaceuticals Company Details
    Table 86. Arena Pharmaceuticals Business Overview
    Table 87. Arena Pharmaceuticals Sickle Cell Disease Treatments Product
    Table 88. Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 89. Arena Pharmaceuticals Recent Development
    Table 90. Alnylam Pharmaceuticals Company Details
    Table 91. Alnylam Pharmaceuticals Business Overview
    Table 92. Alnylam Pharmaceuticals Sickle Cell Disease Treatments Product
    Table 93. Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2017-2022) & (US$ Million)
    Table 94. Alnylam Pharmaceuticals Recent Development
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sickle Cell Disease Treatments Product Picture
    Figure 2. Global Sickle Cell Disease Treatments Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Sickle Cell Disease Treatments Market Size 2017-2028 (US$ Million)
    Figure 4. United States Sickle Cell Disease Treatments Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Sickle Cell Disease Treatments Market Size 2017-2028 (US$ Million)
    Figure 6. United States Sickle Cell Disease Treatments Market Share in Global 2017-2028
    Figure 7. Sickle Cell Disease Treatments Report Years Considered
    Figure 8. Product Picture of Infection Prevention with Vaccination and Antibiotics
    Figure 9. Product Picture of Blood Transfusion
    Figure 10. Product Picture of The Medication Hydroxycarbamide
    Figure 11. Product Picture of A Transplant of Bone Marrow Cells
    Figure 12. Global Sickle Cell Disease Treatments Market Share by Type in 2022 & 2028
    Figure 13. Global Sickle Cell Disease Treatments Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Sickle Cell Disease Treatments Market Share by Type (2017-2028)
    Figure 15. United States Sickle Cell Disease Treatments Market Share by Type in 2022 & 2028
    Figure 16. United States Sickle Cell Disease Treatments Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Sickle Cell Disease Treatments Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Ambulatory Surgical Centers
    Figure 20. Product Picture of Clinics
    Figure 21. Product Picture of Others
    Figure 22. Global Sickle Cell Disease Treatments Market Share by Application in 2022 & 2028
    Figure 23. Global Sickle Cell Disease Treatments Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Sickle Cell Disease Treatments Market Share by Application (2017-2028)
    Figure 25. United States Sickle Cell Disease Treatments Market Share by Application in 2022 & 2028
    Figure 26. United States Sickle Cell Disease Treatments Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Sickle Cell Disease Treatments Market Share by Application (2017-2028)
    Figure 28. North America Sickle Cell Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Sickle Cell Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Sickle Cell Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Sickle Cell Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Sickle Cell Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. U.A.E Sickle Cell Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. AstraZeneca Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 57. Eli Lilly Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 60. Pfizer Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 61. Baxter Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 62. Emmaus Life Sciences Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 63. Bluebird Bio Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 64. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 65. Sangamo Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 66. Acceleron Pharma Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 67. Arena Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 68. Alnylam Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatments Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed